Fundraising Fox

Zurex Pharma

Middleton, US · Wisconsin corporation · 2 known investors

Biotech

Founders & leadership

AM
Andrew MorganinExecutive
AM
Alexander M. KasperExecutive
CJ
Carmine J. DurhaminExecutive
RA
Roy A. MorganExecutive

Board

MJ
Michael J. LiangBoard director
FA
Frederick A. RobertsonBoard director
RB
Robert B. TruittBoard director
CC
Connie CurranBoard director

Investors · 2

Baird Venture PartnersreportedChicago
Wisconsin Investment PartnersreportedMadison · $5K – $100K

Reported raises · per SEC filings

Form D private placements

$23.9M disclosed across 5 rounds · 2014–2023

▶$3.8MraisedDec 2023 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander M KasperExecutive Officer, Director
  • Frederick A. RobertsonDirector
Offering amount
$4M
Amount sold
$3.8M
Minimum investment
$50K
First sale
Dec 2023
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedJun 2020 · 18 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick A. RobertsonDirector
  • Michael J. LiangDirector
  • Carmine J DurhamExecutive Officer, Director
  • Alexander M KasperExecutive Officer
  • Roy Andrew MorganExecutive Officer
  • Robert TruittDirector
Offering amount
$15M
Amount sold
$7.5M
First sale
Jun 2020
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2018 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert B. TruittDirector
  • Carmine J. DurhamExecutive Officer, Director
  • Frederick A. RobertsonDirector
  • Andrew MorganExecutive Officer
  • Michael J. LiangDirector
  • Alexander M. KasperExecutive Officer
Offering amount
$3M
Amount sold
$2.2M
First sale
May 2018
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedAug 2016 · 26 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. LiangDirector
  • Andrew MorganExecutive Officer
  • Frederick A. RobertsonDirector
  • Robert B. TruittDirector
  • Alexander M. KasperExecutive Officer
  • Carmine J. DurhamExecutive Officer, Director
Offering amount
$8M
Amount sold
$6.2M
First sale
Aug 2016
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedJul 2014 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LiangDirector
  • Alexander M. KasperExecutive Officer
  • Robert B. TruittDirector
  • Roy A. MorganExecutive Officer
  • Frederick A. RobertsonExecutive Officer, Director
  • Connie CurranDirector
  • Carmine J. DurhamExecutive Officer, Director
Offering amount
$5.1M
Amount sold
$4.1M
First sale
Jun 2014
Incorporated
Corporation, Wisconsin
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Zurex Pharma moves toward filing for FDA approval of its surgical antiseptic | AP Newsapnews.com · Jul 2018JSOnline: Zurex Pharma raises $6 million - Wisconsin Technology Councilwisconsintechnologycouncil.com · Aug 2016Zurex Pharma raises $6 millionjsonline.com · Aug 2016Middleton's Zurex Pharma raises $5.1 million from investorsarchive.jsonline.com · Jul 2014Madison biotech Zurex Pharma gets $6.2 million funding boostmadison.com · May 2012Zurex Pharma, Inc. Raises $6.2 Million - BioSpacebiospace.com · May 2012

Frequently asked questions

Who are Zurex Pharma's investors?
Zurex Pharma's investors include Baird Venture Partners, Wisconsin Investment Partners.
How much funding has Zurex Pharma raised?
Zurex Pharma has disclosed $23.9M raised across 5 rounds.
Where is Zurex Pharma headquartered?
Zurex Pharma is headquartered in Middleton, US.